Milestone Scientific Issues Update on New Business Activities in China

PISCATAWAY, N.J., March 26 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today issued a formal corporate update relating to the Company's new business opportunities in China.  Specifically, Milestone is currently working in concert with its Chinese distribution partner, China National Medicines Corporation (d/b/a "Sinopharm") to advance the STA System^™ through the required regulatory review and approval process at the State Food and Drug Administration (SFDA) for the People's Republic of China. Upon receiving SFDA clearance, which Sinopharm expects within the next 90 to 120 days, Milestone expects to commence shipments of the STA System to China, pursuant to the terms and conditions defined in the three-year blanket purchase order issued to the Company by Sinopharm late last year.

In addition, Milestone today reported that it is working towards a definitive agreement for the proposed joint venture with China National Medicines Corporation and Yichang Humanwell Pharmaceutical Co. Ltd.  As announced on December 3, 2009, the joint venture will provide the framework for the development and commercialization of two new computer-controlled injection instruments utilizing Milestone's patented CompuFlo^® technology.  These new instruments will focus exclusively on the administration of epidural and intra-articular injections.  At this time, the PRC partners are in discussions with each other regarding their respective ownership interests in the proposed joint venture.

About China National Medicines Corporation

Traded on the Shanghai Stock Exchange (SHA: 600511), China National Medicines Corporation, d/b/a Sinopharm, is China's largest domestic manufacturer, distributor and marketer of pharmaceuticals and importer of medical devices.

About Yichang Humanwell Pharmaceutical Co. Ltd.

Yichang Humanwell Pharmaceutical Co. Ltd. is a major nationally designated anesthetics manufacturer in the PRC.  It maintains a major R&D center with strong research and development capability and has established relationships with a number of PRC universities, including China Pharmaceutical University, Peking University Health Science Center, Huaxi Medical University, and Hua Zhong University of Science and Technology Tongji Medical College.

About Milestone Scientific Inc.

Headquartered in Piscataway, New Jersey, Milestone Scientific is engaged in pioneering advanced computer-controlled injection technologies for the medical and dental markets; and currently sells its award-winning products through a global distribution network serving North America, Asia, Africa and Europe.  For more information on the STA System and other innovative Milestone products, please visit the Company's web sites found at www.milestonescientific.com and www.STAis4U.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success.  These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report  for the year ended December 31, 2009. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof.  Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

SOURCE Milestone Scientific Inc.